Sex-specific Trajectories of Insulin Resistance Markers and Reduced Renal Function During 18 Years of Follow-up: TLGS

Abstract Context The evidence suggest that insulin resistance (IR) complicates chronic kidney disease (CKD); however, the longitudinal association of IR with development of CKD is unknown. Objective This work aimed to investigate the association between the dynamic course of insulin resistance and C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical endocrinology and metabolism 2023-06, Vol.108 (6), p.e230-e239
Hauptverfasser: Amouzegar, Atieh, Honarvar, Mohammadjavad, Masoumi, Safdar, Tohidi, Maryam, Mehran, Ladan, Azizi, Fereidoun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e239
container_issue 6
container_start_page e230
container_title The journal of clinical endocrinology and metabolism
container_volume 108
creator Amouzegar, Atieh
Honarvar, Mohammadjavad
Masoumi, Safdar
Tohidi, Maryam
Mehran, Ladan
Azizi, Fereidoun
description Abstract Context The evidence suggest that insulin resistance (IR) complicates chronic kidney disease (CKD); however, the longitudinal association of IR with development of CKD is unknown. Objective This work aimed to investigate the association between the dynamic course of insulin resistance and CKD. Methods In the longitudinal, population-based Tehran Lipid and Glucose Study, 3071 eligible participants aged 20 years or older were followed for 18 years at 3-year intervals. Homeostatic model assessment of insulin resistance (HOMA-IR) and clinical surrogate markers of IR, including triglyceride-glucose index (TyG), visceral adiposity index (VAI), and lipid accumulation product (LAP), were calculated. Using latent variable mixture modeling, sex-specific trajectories were plotted for each IR marker. Trajectory group association of the IR markers with CKD was determined using the multivariable Cox proportional-hazards regression model. Results For HOMA-IR, 2 distinct trajectory patterns (stable and increasing), and for TyG, VAI, and LAP, 3 trajectories (low, moderate, and high) were identified. The participants with an increasing HOMA-IR trajectory had a significantly increased risk of CKD in men (hazard ratio [HR]: 1.72; 95% CI, 1.06-2.79) and women (HR: 1.37; 95% CI, 1.00-1.89) after adjusting for confounding variables. The high TyG and VAI trajectory classes were associated with a higher risk of CKD than the low TyG and VAI trajectory classes both in men (TyG: HR: 1.97; 95% CI, 1.12-3.46; VAI: HR:1.66; 95% CI, 1.06-2.62) and women (TyG: HR: 1.50; 95% CI, 1.06-2.12; VAI: HR:1.66; 95% CI, 1.20-2.31). In contrast, the high LAP (HR: 3.38; 95% CI, 2.08-5.48) trajectory was associated with incident CKD only in women. Conclusion An increasing trend of HOMA-IR is associated with a higher risk of CKD in men and women. Among clinical IR surrogate markers, abnormal trajectory patterns of LAP in women and TyG and VAI in both sexes are associated with a higher risk of CKD.
doi_str_mv 10.1210/clinem/dgac735
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2757055022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A775957859</galeid><oup_id>10.1210/clinem/dgac735</oup_id><sourcerecordid>A775957859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-d1a61abacead3115ed3f1a80ecd65f0a41c07c9f31b3a4c1643020b3505e80543</originalsourceid><addsrcrecordid>eNqFkU2LFDEQhoMo7jh69SgBL3ro3aSTdLq9LauzLowI7gh6CjXp6iFjd9ImHdR_b48zKsiC1KGgeOqtj5eQp5yd85KzC9s7j8NFuwOrhbpHFryRqtC80ffJgrGSF40uP52RRyntGeNSKvGQnIlKyUo1YkHyLX4v0ojWdc7STYQ92ilEh4mGjt74lOcB9AMmlybwFuk7iF8wJgq-nctttnjIHnq6yt5OLnj6Okfnd5TX9DNC_CW0Cn0fvhV5fEU36-vbx-RBB33CJ6e8JB9XbzZXb4v1--ubq8t1YWUpp6LlUHHYgkVoBecKW9FxqBnatlIdA8kt07bpBN8KkJZXUrCSbYViCmumpFiSF0fdMYavGdNkBpcs9j14DDmZUivNlGJlOaPP_0H3Icf5rmQEU1zXZcX4X2oHPRrnuzBFsAdRc6m1apSu57cuyfkd1BwtDs4Gj52b63c12BhSitiZMboB4g_DmTn4bI4-m5PPc8Oz07Z5O2D7B_9t7Ay8PAIhj_8T-wkKtbGd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3051782601</pqid></control><display><type>article</type><title>Sex-specific Trajectories of Insulin Resistance Markers and Reduced Renal Function During 18 Years of Follow-up: TLGS</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Amouzegar, Atieh ; Honarvar, Mohammadjavad ; Masoumi, Safdar ; Tohidi, Maryam ; Mehran, Ladan ; Azizi, Fereidoun</creator><creatorcontrib>Amouzegar, Atieh ; Honarvar, Mohammadjavad ; Masoumi, Safdar ; Tohidi, Maryam ; Mehran, Ladan ; Azizi, Fereidoun</creatorcontrib><description>Abstract Context The evidence suggest that insulin resistance (IR) complicates chronic kidney disease (CKD); however, the longitudinal association of IR with development of CKD is unknown. Objective This work aimed to investigate the association between the dynamic course of insulin resistance and CKD. Methods In the longitudinal, population-based Tehran Lipid and Glucose Study, 3071 eligible participants aged 20 years or older were followed for 18 years at 3-year intervals. Homeostatic model assessment of insulin resistance (HOMA-IR) and clinical surrogate markers of IR, including triglyceride-glucose index (TyG), visceral adiposity index (VAI), and lipid accumulation product (LAP), were calculated. Using latent variable mixture modeling, sex-specific trajectories were plotted for each IR marker. Trajectory group association of the IR markers with CKD was determined using the multivariable Cox proportional-hazards regression model. Results For HOMA-IR, 2 distinct trajectory patterns (stable and increasing), and for TyG, VAI, and LAP, 3 trajectories (low, moderate, and high) were identified. The participants with an increasing HOMA-IR trajectory had a significantly increased risk of CKD in men (hazard ratio [HR]: 1.72; 95% CI, 1.06-2.79) and women (HR: 1.37; 95% CI, 1.00-1.89) after adjusting for confounding variables. The high TyG and VAI trajectory classes were associated with a higher risk of CKD than the low TyG and VAI trajectory classes both in men (TyG: HR: 1.97; 95% CI, 1.12-3.46; VAI: HR:1.66; 95% CI, 1.06-2.62) and women (TyG: HR: 1.50; 95% CI, 1.06-2.12; VAI: HR:1.66; 95% CI, 1.20-2.31). In contrast, the high LAP (HR: 3.38; 95% CI, 2.08-5.48) trajectory was associated with incident CKD only in women. Conclusion An increasing trend of HOMA-IR is associated with a higher risk of CKD in men and women. Among clinical IR surrogate markers, abnormal trajectory patterns of LAP in women and TyG and VAI in both sexes are associated with a higher risk of CKD.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/clinem/dgac735</identifier><identifier>PMID: 36546593</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adipose tissue ; Adipose tissues ; Biomarkers ; Blood Glucose ; Chronic kidney failure ; Dextrose ; Female ; Glucose ; Humans ; Hyperinsulinism ; Hypoglycemic agents ; Insulin Resistance ; Iran - epidemiology ; Kidney - physiology ; Kidney diseases ; Male ; Renal function ; Renal Insufficiency, Chronic - epidemiology ; Triglycerides ; Type 2 diabetes ; Women</subject><ispartof>The journal of clinical endocrinology and metabolism, 2023-06, Vol.108 (6), p.e230-e239</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022</rights><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><rights>COPYRIGHT 2023 Oxford University Press</rights><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-d1a61abacead3115ed3f1a80ecd65f0a41c07c9f31b3a4c1643020b3505e80543</citedby><cites>FETCH-LOGICAL-c424t-d1a61abacead3115ed3f1a80ecd65f0a41c07c9f31b3a4c1643020b3505e80543</cites><orcidid>0000-0002-3650-4951 ; 0000-0001-8568-7419 ; 0000-0001-9433-9408</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36546593$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amouzegar, Atieh</creatorcontrib><creatorcontrib>Honarvar, Mohammadjavad</creatorcontrib><creatorcontrib>Masoumi, Safdar</creatorcontrib><creatorcontrib>Tohidi, Maryam</creatorcontrib><creatorcontrib>Mehran, Ladan</creatorcontrib><creatorcontrib>Azizi, Fereidoun</creatorcontrib><title>Sex-specific Trajectories of Insulin Resistance Markers and Reduced Renal Function During 18 Years of Follow-up: TLGS</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Abstract Context The evidence suggest that insulin resistance (IR) complicates chronic kidney disease (CKD); however, the longitudinal association of IR with development of CKD is unknown. Objective This work aimed to investigate the association between the dynamic course of insulin resistance and CKD. Methods In the longitudinal, population-based Tehran Lipid and Glucose Study, 3071 eligible participants aged 20 years or older were followed for 18 years at 3-year intervals. Homeostatic model assessment of insulin resistance (HOMA-IR) and clinical surrogate markers of IR, including triglyceride-glucose index (TyG), visceral adiposity index (VAI), and lipid accumulation product (LAP), were calculated. Using latent variable mixture modeling, sex-specific trajectories were plotted for each IR marker. Trajectory group association of the IR markers with CKD was determined using the multivariable Cox proportional-hazards regression model. Results For HOMA-IR, 2 distinct trajectory patterns (stable and increasing), and for TyG, VAI, and LAP, 3 trajectories (low, moderate, and high) were identified. The participants with an increasing HOMA-IR trajectory had a significantly increased risk of CKD in men (hazard ratio [HR]: 1.72; 95% CI, 1.06-2.79) and women (HR: 1.37; 95% CI, 1.00-1.89) after adjusting for confounding variables. The high TyG and VAI trajectory classes were associated with a higher risk of CKD than the low TyG and VAI trajectory classes both in men (TyG: HR: 1.97; 95% CI, 1.12-3.46; VAI: HR:1.66; 95% CI, 1.06-2.62) and women (TyG: HR: 1.50; 95% CI, 1.06-2.12; VAI: HR:1.66; 95% CI, 1.20-2.31). In contrast, the high LAP (HR: 3.38; 95% CI, 2.08-5.48) trajectory was associated with incident CKD only in women. Conclusion An increasing trend of HOMA-IR is associated with a higher risk of CKD in men and women. Among clinical IR surrogate markers, abnormal trajectory patterns of LAP in women and TyG and VAI in both sexes are associated with a higher risk of CKD.</description><subject>Adipose tissue</subject><subject>Adipose tissues</subject><subject>Biomarkers</subject><subject>Blood Glucose</subject><subject>Chronic kidney failure</subject><subject>Dextrose</subject><subject>Female</subject><subject>Glucose</subject><subject>Humans</subject><subject>Hyperinsulinism</subject><subject>Hypoglycemic agents</subject><subject>Insulin Resistance</subject><subject>Iran - epidemiology</subject><subject>Kidney - physiology</subject><subject>Kidney diseases</subject><subject>Male</subject><subject>Renal function</subject><subject>Renal Insufficiency, Chronic - epidemiology</subject><subject>Triglycerides</subject><subject>Type 2 diabetes</subject><subject>Women</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2LFDEQhoMo7jh69SgBL3ro3aSTdLq9LauzLowI7gh6CjXp6iFjd9ImHdR_b48zKsiC1KGgeOqtj5eQp5yd85KzC9s7j8NFuwOrhbpHFryRqtC80ffJgrGSF40uP52RRyntGeNSKvGQnIlKyUo1YkHyLX4v0ojWdc7STYQ92ilEh4mGjt74lOcB9AMmlybwFuk7iF8wJgq-nctttnjIHnq6yt5OLnj6Okfnd5TX9DNC_CW0Cn0fvhV5fEU36-vbx-RBB33CJ6e8JB9XbzZXb4v1--ubq8t1YWUpp6LlUHHYgkVoBecKW9FxqBnatlIdA8kt07bpBN8KkJZXUrCSbYViCmumpFiSF0fdMYavGdNkBpcs9j14DDmZUivNlGJlOaPP_0H3Icf5rmQEU1zXZcX4X2oHPRrnuzBFsAdRc6m1apSu57cuyfkd1BwtDs4Gj52b63c12BhSitiZMboB4g_DmTn4bI4-m5PPc8Oz07Z5O2D7B_9t7Ay8PAIhj_8T-wkKtbGd</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Amouzegar, Atieh</creator><creator>Honarvar, Mohammadjavad</creator><creator>Masoumi, Safdar</creator><creator>Tohidi, Maryam</creator><creator>Mehran, Ladan</creator><creator>Azizi, Fereidoun</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3650-4951</orcidid><orcidid>https://orcid.org/0000-0001-8568-7419</orcidid><orcidid>https://orcid.org/0000-0001-9433-9408</orcidid></search><sort><creationdate>20230601</creationdate><title>Sex-specific Trajectories of Insulin Resistance Markers and Reduced Renal Function During 18 Years of Follow-up: TLGS</title><author>Amouzegar, Atieh ; Honarvar, Mohammadjavad ; Masoumi, Safdar ; Tohidi, Maryam ; Mehran, Ladan ; Azizi, Fereidoun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-d1a61abacead3115ed3f1a80ecd65f0a41c07c9f31b3a4c1643020b3505e80543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adipose tissue</topic><topic>Adipose tissues</topic><topic>Biomarkers</topic><topic>Blood Glucose</topic><topic>Chronic kidney failure</topic><topic>Dextrose</topic><topic>Female</topic><topic>Glucose</topic><topic>Humans</topic><topic>Hyperinsulinism</topic><topic>Hypoglycemic agents</topic><topic>Insulin Resistance</topic><topic>Iran - epidemiology</topic><topic>Kidney - physiology</topic><topic>Kidney diseases</topic><topic>Male</topic><topic>Renal function</topic><topic>Renal Insufficiency, Chronic - epidemiology</topic><topic>Triglycerides</topic><topic>Type 2 diabetes</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amouzegar, Atieh</creatorcontrib><creatorcontrib>Honarvar, Mohammadjavad</creatorcontrib><creatorcontrib>Masoumi, Safdar</creatorcontrib><creatorcontrib>Tohidi, Maryam</creatorcontrib><creatorcontrib>Mehran, Ladan</creatorcontrib><creatorcontrib>Azizi, Fereidoun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amouzegar, Atieh</au><au>Honarvar, Mohammadjavad</au><au>Masoumi, Safdar</au><au>Tohidi, Maryam</au><au>Mehran, Ladan</au><au>Azizi, Fereidoun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sex-specific Trajectories of Insulin Resistance Markers and Reduced Renal Function During 18 Years of Follow-up: TLGS</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>108</volume><issue>6</issue><spage>e230</spage><epage>e239</epage><pages>e230-e239</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Abstract Context The evidence suggest that insulin resistance (IR) complicates chronic kidney disease (CKD); however, the longitudinal association of IR with development of CKD is unknown. Objective This work aimed to investigate the association between the dynamic course of insulin resistance and CKD. Methods In the longitudinal, population-based Tehran Lipid and Glucose Study, 3071 eligible participants aged 20 years or older were followed for 18 years at 3-year intervals. Homeostatic model assessment of insulin resistance (HOMA-IR) and clinical surrogate markers of IR, including triglyceride-glucose index (TyG), visceral adiposity index (VAI), and lipid accumulation product (LAP), were calculated. Using latent variable mixture modeling, sex-specific trajectories were plotted for each IR marker. Trajectory group association of the IR markers with CKD was determined using the multivariable Cox proportional-hazards regression model. Results For HOMA-IR, 2 distinct trajectory patterns (stable and increasing), and for TyG, VAI, and LAP, 3 trajectories (low, moderate, and high) were identified. The participants with an increasing HOMA-IR trajectory had a significantly increased risk of CKD in men (hazard ratio [HR]: 1.72; 95% CI, 1.06-2.79) and women (HR: 1.37; 95% CI, 1.00-1.89) after adjusting for confounding variables. The high TyG and VAI trajectory classes were associated with a higher risk of CKD than the low TyG and VAI trajectory classes both in men (TyG: HR: 1.97; 95% CI, 1.12-3.46; VAI: HR:1.66; 95% CI, 1.06-2.62) and women (TyG: HR: 1.50; 95% CI, 1.06-2.12; VAI: HR:1.66; 95% CI, 1.20-2.31). In contrast, the high LAP (HR: 3.38; 95% CI, 2.08-5.48) trajectory was associated with incident CKD only in women. Conclusion An increasing trend of HOMA-IR is associated with a higher risk of CKD in men and women. Among clinical IR surrogate markers, abnormal trajectory patterns of LAP in women and TyG and VAI in both sexes are associated with a higher risk of CKD.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>36546593</pmid><doi>10.1210/clinem/dgac735</doi><orcidid>https://orcid.org/0000-0002-3650-4951</orcidid><orcidid>https://orcid.org/0000-0001-8568-7419</orcidid><orcidid>https://orcid.org/0000-0001-9433-9408</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The journal of clinical endocrinology and metabolism, 2023-06, Vol.108 (6), p.e230-e239
issn 0021-972X
1945-7197
language eng
recordid cdi_proquest_miscellaneous_2757055022
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adipose tissue
Adipose tissues
Biomarkers
Blood Glucose
Chronic kidney failure
Dextrose
Female
Glucose
Humans
Hyperinsulinism
Hypoglycemic agents
Insulin Resistance
Iran - epidemiology
Kidney - physiology
Kidney diseases
Male
Renal function
Renal Insufficiency, Chronic - epidemiology
Triglycerides
Type 2 diabetes
Women
title Sex-specific Trajectories of Insulin Resistance Markers and Reduced Renal Function During 18 Years of Follow-up: TLGS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A44%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sex-specific%20Trajectories%20of%20Insulin%20Resistance%20Markers%20and%20Reduced%20Renal%20Function%20During%2018%20Years%20of%20Follow-up:%20TLGS&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Amouzegar,%20Atieh&rft.date=2023-06-01&rft.volume=108&rft.issue=6&rft.spage=e230&rft.epage=e239&rft.pages=e230-e239&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/clinem/dgac735&rft_dat=%3Cgale_proqu%3EA775957859%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3051782601&rft_id=info:pmid/36546593&rft_galeid=A775957859&rft_oup_id=10.1210/clinem/dgac735&rfr_iscdi=true